The Medical Affairs function is in the process of evolving from a traditional support role (Medical Affairs 1.0) into a more robust, strategic organization for data generation and dissemination (Medical Affairs 2.0). Product early-development phase: to create external expert interest. We use cookies to ensure that we give you the best experience on our website. It sets general guidelines for … Our flagship business publication has been defining and informing the senior-management agenda since 1964. I provide medical affairs and company wide compliance solutions to the pharmaceutical industry. Now, the function is strategic … Medical Affairs—a third strategic pillar for the pharmaceutical enterprise Innovation in both digital technology and the biological sciences is advancing at a furious pace, while the quantity of data generated is skyrocketing. hereLearn more about cookies, Opens in new The pharmaceutical industry must rise to new challenges, market access, value-based healthcare and outcome management are key topics, Creating meaningful impact in healthcare & life sciences together. Launch phase: to educate on clinical evidence and product use. In a healthcare environment that is increasingly complex, unpredictable, and regulated, Medical Affairs should devote early focus to building strategic a… Apply to Program Officer, Program Manager, US Commercial Country Lead and more! We use cookies essential for this site to function well. The winners will be those who succeed in positioning their science—especially their ability to combine, analyze, and interpret disparate data sets—to inform their interactions with stakeholders and ultimately improve patient outcomes. They are responsible to collect and report insights. Find out more about a career in Medical Affairs below, take a look at our jobs or speak with our specialist consultant Danielle Bent for an informal chat: +44 (0)1625 541 046 / danielle@carrotpharma.co.uk . As a driving force that combines clinical and medical evidence within the organization and presents it to stakeholders, Medical Affairs is able to communicate the company’s value proposition in a balanced and evidence-based manner. The future will see a broad expansion of medical engagement across providers, patients, and others—across a range of touchpoints that will be increasingly digital—designed to provide tailored information, support tools, and innovative approaches to education focused on improving outcomes. This offers medical affairs the opportunity to forge a new role as a primary strategic pillar of the organization alongside research and development, as well as commercial and market-access functions. Medical Affairs sits within commercial organisations and is concerned with post-approval activities. Medical Affairs strategic plans include both intellectual components, such as situational analyses and medical strategies, as well as tactical components, including tactical and operational plans, and assessment and measurement metrics. A radical transformation of medical leadership will see medical affairs leading from the C-suite, transforming public opinion of the industry, putting the patient front and center, and rethinking how company performance is measured to prioritize improved patient outcomes. This process helps to put insights into context and turn them into action. Fast forward and medical affairs now encompasses strategy, safety, communications, post-launch trials, field teams and much more – a sort of command central of pharma. Medical Affairs is uniquely positioned to respond to market trends: Medical Affairs is capable to overcome difficulties on integrating disparate data sources and respond to customer needs. Dan Hennessy, PhD, MS, MBA, is a VP of Strategic Excellence, North America Medical Affairs at EMD Serono and has over 18 years track record of significant contributions to medical affairs and clinical development of hematology/oncology and other specialty drug therapies. Reinvent your business. Medical Affairs is uniquely positioned to connect stakeholders We are reaching a turning point in healthcare; aging populations and rise in chronic diseases are amplifying medical needs, whilst unprecedented number of innovations and breakthrough treatments is exerting ever greater pressure on healthcare budgets. The Director, Medical Affairs, will be a key individual to provide scientific leadership and guidance in the area of brand strategy and post approval research. We see this transformation happening across three dimensions: a) elevation of medical strategic planning across all critical processes within and outside of medical affairs, b) an imperative to acquire and nurture strategic medical talent, and c) a focus on performance management and resource allocation to elevate performance. Today we see an even clearer case for medical affairs taking on a more strategic leadership role in the face of current technology, economic, and regulatory trends. Examine and identify business needs to create a business case to showcase the benefits and how costs will go down in the future Understand the reimbursement landscape There is an increased trend to evidence-based decisions. Thanks for your interest in the Medical Affairs Strategy Specialist position. Learn how medical affairs can enhance the commercial success of pharma brands with market insight generation, brand value definition, and HCP/patient engagement – Learn the critical success factors of a competitive medical affairs strategy and of an impactful tactical mix – Get familiar with the fundamentals of health economics and of leadership development. Matthias Evers is a senior partner in McKinsey’s Hamburg office, Arnie Ghatak is a senior partner in the New Jersey office, Brindan Suresh is a partner in the London office, and Ann Westra is a senior expert in the Minneapolis office. Medical affairs teams need to align a strategy to communicate the value of these tools to their organizations. The ideal candidate will have experience working across several functions in oncology. Flip the odds. Agenda of The Strategic e-Medical Affairs Course. They engage with external stakeholders into value and science discussions. The medical support needs of novel therapies necessitates a strategic evaluation of the medical affairs function. Medical education has the highest impact on net promoter score (NPS) and awareness among the medical channels and HCP’s express clear desire for increased channel use. Effective engagements also create clinical awareness and help improve health outcomes by shaping treatment paradigms. cookies, Pharmaceutical & Medical Products Practice. The focus of the role will be to provide strategic medical and scientific leadership to ensure a successful launch for adagrasib. There is an overwhelming need to embrace the power of data and analytics, as well as digital-engagement techniques. Examples of our projects in Medical Affairs strategy: Medical Affairs is the medical face of (bio)pharmaceutical companies: Webinar: Medical Affairs delivering optimum care. The insights collection should aim to close internal data or knowledge gaps. A strategic vision for the Medical Affairs organization To help our clients provide clinical insights that drive innovation and demonstrate real world evidence of improved outcomes, we have developed a strategic vision for MA based on four pillars of excellence. We expect to see a clear articulation of clinical and economic value to providers, corporatized providers, and patients. Medical affairs has the prominent role of helping healthcare practitioners (HCPs) navigate vast quantities of information and understand how to use new products for the best patient outcomes. They engage with external stakeholders into value and science discussions. We'll email you when new articles are published on this topic. Learn more about cookies, Opens in new Directly address patient medical needs, for example, through a seamless combination of engagement on social platforms and new tools that support patients on their medical journey. Rapid-cycle, integrated evidence generation across health economics and outcomes research (HEOR), RWE, Phase IIIb/IV studies, and so on will be supported by microanalysis that tailors the vast amount of available information to the needs of individual patients. Business models are starting to evolve both around and beyond the “product” to encompass the wider therapeutic context, while organizations seek to explain and contextualize the ever-more-complex medical science to a diverse range of stakeholders (physicians, patients, payers). therapeutic space. Medical Affairs is both strategically and operationally critical in planning, creating, and delivering differentiated scientific and clinical value in product launch readiness planning. Learn about part of the tasks assigned to medical affairs. Subscribed to {PRACTICE_NAME} email alerts. They are involved into the planning and generating evidence. Post-launch phase: to provide continued medical education. Advanced analytics of patient data have become central to supporting decision making on product use and to demonstrating patient value. This will include data generation, data analysis and interpretation, medical support for publications and … Never miss an insight. Innovation in both digital technology and the bio sciences is advancing at a furious pace, while the quantity of data generated is skyrocketing. A radical transformation of medical leadership will see medical affairs leading from the C-suite, transforming public opinion of the industry, putting the patient front and center, and rethinking how company performance is measured to prioritize improved patient outcomes. The four pillars can With an informed and rational communication strategy, communication point matrix, and data dissemination plan in place, medical affairs, as one of their core competencies, can gain support and input from the primary audiences (e.g., thought leaders, investigators, clinicians, payers, and patients) on the overall strategy. RWE, to meet decision maker demands; Patients will have value-based outcomes translated into real-world benefits, improved health benefits and better patient experience. Estimates suggest that 2.5 quintillion Medical Affairs need to take into consideration different elements to a more efficient and integrated approach to evidence planning and generation. The [Medical Affairs] function is more strategic as we act as ambassadors and facilitators of information exchange, delivering insights back into Development. Practical resources to help leaders navigate to the next normal: guides, tools, checklists, interviews and more. The Director, Medical Affairs Strategy is a versatile, flexible and experienced professional with medical oncology expertise. McKinsey Insights - Get our latest thinking on your iPhone, iPad, or Android device. For decades the medical affairs role was defined primarily by information support and the management of routine regulatory reporting requirements. tab, Travel, Logistics & Transport Infrastructure, McKinsey Institute for Black Economic Mobility. They are responsible for educating internal and external stakeholders on scientific topics, care pathway and patient outcomes. collaboration with select social media and trusted analytics partners tab. our use of cookies, and 2 Medical plans are important because they guide decision making across the organization and support the communication and assessment of Medical Affairs’ … Track A: Tailor Global Medical Strategy Based on the Needs of Regional Partners Track B: Case Study: Review the Impact of Real-World Evidence on Medical Affairs Strategy Track C: Panel: How Medical Affairs Can Help Prepare the Market for a New Drug Launch Track D: Discuss Key Strategies for your Internal Investigator Initiated Study Operations Transition towards a more competitive and patient-focused organization /, Prioritizing medical resource allocation for optimal patient management support /, Strategy to become leading in patient engagement and advocacy /. Our mission is to help leaders in multiple sectors develop a deeper understanding of the global economy. Focused strategic medical objectives will maximize the overall medical value to the external stakeholders, while upholding the scientific integrity and respectability of the product and pharmaceutical organization that supports it. As described in the book Understanding Pharma: The Professional’s Guide to How Pharmaceutical and Biotech Companies Really Work, when a drug emerges from clinical development and is on the cusp of commercialization, Medical Affairs will lead the effort to explain to potential healthcare prescribers the real-world applications of the drug through the dissemination of unbiased clinical and scientific information. Organizations seeking to develop a best-in-class medical-affairs function should note the following: Embrace the power of technology to transform medical—especially digital, including artificial intelligence and other new tools, advanced analytics, and new data sets—by defining a prioritized set of use cases, building a technology capability stack, and developing a strategic plan for one, three, and five years ahead. Please use UP and DOWN arrow keys to review autocomplete results. Digital upends old models. It calls for a broader set of capabilities, more business acumen and greater alignment with the commercial goals of … The same strategy should be applied to many other functions as well. Press enter to select and open the results on a new page. This imperative is accelerating the evolution of medical affairs as the third strategic pillar of the organization alongside R&D and commercial. Taking ownership of evidence planning and generation benefits the scientific community, the industry, patients and all other relevant stakeholders: A comprehensive insights collection process embraces the insights gathering, reporting and follow-up. Pre-launch phase: to build awareness and confirm product understanding. TMAC Advisors™, the consulting arm of TMAC, is lead by Norm Enriquez, PharmD, and consists of a cadre of recognized medical affairs leaders who have had substantial success as executives at large and small biotechnology companies. Modernize ways of working to embrace new value-creation opportunities and build strategic leadership know-how with enhanced skills and capabilities to cement strong partnerships with R&D and commercial. The online version of this course will cover the same modules, but the format and timing will be adapted to suit the online training setting. Leading Strategies to Advance Medical Science Communications, Engage with KOLs Compliantly, Conduct Effective Investigator Studies and Ensure Excellence Throughout Your Medical Affairs Team A 360 degree view of the medical affairs landscape that brings together Investigator Initiated Sponsored Research (IISR), Expanded Access Programs (EAP) and Medical Publications & Communications. Significant aspects of medical affairs activity need to be updated: for instance, to rethink medical performance management to maximize the impact of medical activities. Sched.com Conference Mobile Apps. Online - See the full schedule of events happening Jun 1 - 5, 2020 and explore the directory of Speakers & Attendees. Unfortunately this position has been closed but you can search our 1,654 open jobs by clicking here. This will involve real-world evidence (RWE), electronic medical records (EMR), and novel sources of data, such as genomics in combination with innovative ways of mining and interpreting that data. Previously, medical affairs disseminated medical information in response to unsolicited requests and facilitated unsolicited grant funding. We will help you navigate through challenging market demands. Medical Affairs teams demonstrate leadership and value each year through the annual strategic planning process that aligns all multifunctional MA competencies on common objectives needed to support the product and organization. Medical-affairs teams, through their deep understanding of science, data capabilities, and their dialogue with stakeholders, will be well positioned to understand how to seek the evidence required to support the entire life cycle of the offering to optimize patient outcomes. Select topics and stay current with our latest insights. Please click "Accept" to help us improve its usefulness with additional cookies. Unleash their potential. Regulatory. How can we provide better, accessible and affordable care? Medical Affairs stands to be one of the most strategically important and valued functions in a pharmaceutical company, as the nexus of cutting-edge medical, scientific and patient-centred insights that drive strategy and innovation throughout the entire product life cycle. This will be supported by robust, customer-centric data models and medically led outcomes-based contracting that provide the required data to ensure the right patient gets the right drug at the right time. Medical affairs plays a pivotal role in communicating with external experts and clinicians, and is key to identifying unmet medical needs, raising awareness with clinicians, and providing valuable feedback and insights that can better inform an organization’s development strategy. Medical Affairs Strategy Medical Affairs is the medical face of (bio)pharmaceutical companies: They are responsible for educating internal and external stakeholders on scientific topics, care pathway and patient outcomes. Check out the schedule for Medical Affairs Strategic Summit East — Virtual. Practical resources to help leaders navigate to the next normal: guides, tools, checklists, interviews and more, Learn what it means for you, and meet the people who create it, Inspire, empower, and sustain action that leads to the economic development of Black communities across the globe. The Value of Medical Affairs: Defining Strategic Metrics to Demonstrate Impact Objectives Strategy into Implementation. This means Medical Affairs must establish and sustain functional effectiveness to optimally deliver the medical platform to support new and meaningful clinical value to patients. The correct communication of real-world evidence, scientific analysis, medical-value insights and in-house data might also guide improved reimbursement algorithms. I am a PhD Regulatory Pharmacist with legal training and certifications in healthcare compliance and various certifications, I provide: Physicians are seeking peer-to-peer interaction in order to engage into value-driven discussions underpinned by science; Increasing pressure to ensure promotional compliance while maintaining full transparency; An integrated approach enables the tailoring of evidence to payers, providers and patients; It benefits industry by checking all evidence required, incl. Medical Affairs need to be prepared to share knowledge and educate internal and external stakeholders throughout all product lifecycle phases: Increased market dynamic, portfolio growth and complex products continually drive the need to strategically allocate medical education budgets to avoid major increase in spending. A far larger and more ambitious vision for medical affairs is defined by the following: How we gather, integrate, and interpret data will define the future. As innovation transforms the healthcare landscape, science and data are becoming the foundation for pharma to meet its obligations to patients and customers—and realize commercial opportunities. Something went wrong. 22 Journal for Clinical Studies Volume 9 Issue 3 Nowadays, medical affairs plays a key role in communication, With this in mind, McKinsey has been working closely with industry executives to create a bold vision for the medical-affairs function in 2025: one that embraces these profound changes and consequently seeks to drive positive impact for patients, caregivers, and healthcare professionals by enhancing medical affairs’ strategic focus and optimizing the impact of its activities. Please try again later. The below detailed agenda is for the face-to-face format. Be sure to register today to secure your spot for this virtual event! 2,816 Medical Affair Strategy Lead jobs available on Indeed.com. With a core focus on medical affairs executive strategy, MSL activities, and investigator-initiated research, this event features entire days dedicated to these groups and allows cross-functional managers and team members to align their strategies and tactics in an effective way. Its function is similar to that of Global Marketing—that is to say, Global Medical Affairs defines a broad overall medical affairs strategy and ensures that the activities across markets are aligned and that redundant efforts are avoided. Use minimal essential A key example is health economics and outcomes research. People create and sustain change. The winners in an era of Big Data will transform medical affairs teams into medical value teams with three strategic roles: communicating scientific evidence, providing market-based strategic input to drug development and portfolio management, and overseeing the effort to produce Big Data and real-world evidence. If you continue to use this site we'll assume that you agree with our privacy policy. The authors wish to thank Elizabeth Holt, Ivan Ostojic, Claudia Pradel, and Alexandra Zemp for their contributions to this article. Seek out cross-industry collaboration to advance the function and build talent—examples include PhactMI, the Medical Affairs Leadership Academy (MALA), and the Medical Affairs Professional Society (MAPS). Most transformations fail. Measure how the organization performs in terms of maximizing patient outcomes both by understanding the real-world consequences of specific medical-affairs activities and then also having the performance-management capability to make better use of such insights to drive the excellence of the right activity. We can help you develop a stronger, more strategic and high-performing team and by aligning your strategy with the needs of different stakeholders. What is Medical Affairs? Download the full paper from which this article is adapted, A vision for medical affairs in 2025 (PDF-2.4MB).